Skip to Main Content

Paper Details

Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
126
2014
BCG, BCG genomic DNA, BCG-specific CD8(+) T cells, Bacillus Calmette, C57Bl, NMIBC, PARTICIPANTS, PATIENT, Patients, T-cell, bacillus, bacillus Calmette, bladder cancer, mice, non-muscle-invasive bladder cancer, patients, reference genomes
Author NameAffiliation
Aurélie BisiauxInstitut Pasteur, France Inserm U
Matthew L AlbertInstitut Pasteur, France Inserm U, France Universite Paris Descartes, France Center for Human Immunology
  • 1 - 2

Datasets

Release 1.2